tiprankstipranks
Advertisement
Advertisement
Prime Medicine reports positive resolution to arbitration with Beam Therapeutics
PremiumThe FlyPrime Medicine reports positive resolution to arbitration with Beam Therapeutics
1M ago
Ambarella, Beam, United Micro, Hyperscale Data, Atai Beckley Shocking Insider Moves
Premium
Weekend Updates
Ambarella, Beam, United Micro, Hyperscale Data, Atai Beckley Shocking Insider Moves
1M ago
Beam Therapeutics announces U.S. FDA clearned IND application for BEAM-304
Premium
The Fly
Beam Therapeutics announces U.S. FDA clearned IND application for BEAM-304
2M ago
Beam Therapeutics: Buy Rating Reaffirmed as Clinical Momentum Builds and $68 Price Target Remains Unchanged
PremiumRatingsBeam Therapeutics: Buy Rating Reaffirmed as Clinical Momentum Builds and $68 Price Target Remains Unchanged
3M ago
Beam Therapeutics price target lowered to $39 from $40 at Bernstein
Premium
The Fly
Beam Therapeutics price target lowered to $39 from $40 at Bernstein
3M ago
FDA Commissioner Marty Makary resigns
Premium
The Fly
FDA Commissioner Marty Makary resigns
3M ago
Beam Therapeutics rises 10.8%
PremiumThe FlyBeam Therapeutics rises 10.8%
3M ago
Beam Therapeutics: Compelling BEAM-302 Data and Manageable Safety Profile Underpin Buy Rating and Favorable Risk‑Reward
Premium
Ratings
Beam Therapeutics: Compelling BEAM-302 Data and Manageable Safety Profile Underpin Buy Rating and Favorable Risk‑Reward
4M ago
Beam Therapeutics’ risto-cel shows efficacy in Sickle Cell Disease trial
Premium
The Fly
Beam Therapeutics’ risto-cel shows efficacy in Sickle Cell Disease trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100